Y si te interesan las campaas relmpago, activa las notificaciones para no perder periodos cortos con porcentajes mejorados
Retatrutide is a triple-receptor agonist that targets GIP, GLP-1, and glucagon receptors, making it a particularly powerful option for weight management and metabolic health
Another doctor told WSJ that doctors do not have enough evidence to safely prescribe [GLP-1 medications to kids] under 12 at this point. But WSJ reports that more than 20% of U.S
[1] (Current as of mid-2026
Even if it does cause weight loss or a reduction in inflammation, she says, it's unclear whether those results will persist long-term or whether the practice causes harm
J Stud Alcohol Drugs 85:510 Brunchmann A, Thomsen M, Fink-Jensen A (2019) The effect of glucagon-like peptide-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: a systematic review